newsfilter
← Latest News
GlobeNewswire·

Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX), today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a